Filing Details
- Accession Number:
- 0000950170-24-047680
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-24 17:00:16
- Reporting Period:
- 2024-04-22
- Accepted Time:
- 2024-04-24 17:00:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1703647 | Korro Bio Inc. | KRRO | Pharmaceutical Preparations (2834) | 472324450 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1851328 | Rick Yang | 2855 Sand Hill Road Menlo Park CA 94025 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-04-22 | 17,857 | $56.00 | 1,090,793 | No | 4 | P | Indirect | See Note 2 |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Note 2 |
Footnotes
- Acquired from the Issuer on April 22, 2024 pursuant to a Subscription Agreement dated April 17, 2024.
- The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest.